Figure 2.

Biology-driven cancer drug development for CML. From the original description of CML in 1845, fundamental biology has driven the development of treatments for CML. Approximate times are shown for key events in the development of imatinib.

Lord and Ashworth BMC Biology 2010 8:38   doi:10.1186/1741-7007-8-38
Download authors' original image